Additionally, the discovery and treatment of the targetable alterations in hot spot regions in the KIT or PDGFRA genes in gastrointestinal stromal tumors (GIST) has significantly improved overall survival of these patients [9, 10]. Here, PDGFRA is linked to gastrointestinal stromal tumor.